Rudolph et al., 1993 - Google Patents
Discrimination of human T-lymphotropic virus type-I and type-II infections by synthetic peptides representing structural epitopes from the envelope glycoproteinsRudolph et al., 1993
View PDF- Document ID
- 14557700474228445602
- Author
- Rudolph D
- Lal R
- Publication year
- Publication venue
- Clinical chemistry
External Links
Snippet
Synthetic peptides representing the immunodominant structural motifs of the envelope region of human T-lymphotropic virus types I (HTLV-I)(Env-1 (191-214) and Env-5 (242- 257)) and II (HTLV-II)(Env-20 (85-102 and Env-2 (187-209)) were used to develop an …
- 102000004196 processed proteins & peptides 0 title abstract description 32
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
- C07K16/1036—Retroviridae, e.g. leukemia viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Anderson et al. | Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors | |
| Goubau et al. | HTLV-II seroprevalence in pygmies across Africa since 1970 | |
| US6406841B1 (en) | Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides | |
| Lipka et al. | Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes | |
| Lal et al. | Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II | |
| Lal et al. | Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay | |
| Lal et al. | Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals | |
| US6074646A (en) | Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies | |
| US7115363B1 (en) | Retrovirus capable of causing AIDS, means and methods for detecting it in vitro | |
| FUKUSHIMA et al. | Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in South Vietnam | |
| US6531574B1 (en) | T-lymphotrophic virus | |
| AU5283490A (en) | Discrimination between antibodies against htlv-i, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits | |
| Rudolph et al. | Discrimination of human T-lymphotropic virus type-I and type-II infections by synthetic peptides representing structural epitopes from the envelope glycoproteins | |
| Lal et al. | Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I | |
| US5019510A (en) | Isolation, molecular cloning and sequencing of an HIV-1 isolate from a Gabonese donor | |
| Lipka et al. | Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II | |
| Viscidi et al. | Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides | |
| Buckner et al. | Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations | |
| EP0439077B1 (en) | Synthetic peptide compositions with immunoreactivities to antibodies to HTLV | |
| AU641554B2 (en) | Novel peptide antigens and immunoassays, test kits and vaccines using the same | |
| Lal et al. | Differential antibody responsiveness to p19 gag results in serological discrimination between human T lymphotropic virus type I and type II | |
| Medrano et al. | Significance of indeterminate reactivity to human T-cell lymphotropic virus in western blot analysis of individuals at risk | |
| Sibille et al. | Comparison of serological tests for the diagnosis of feline immunodeficiency virus infection of cats | |
| US5378805A (en) | Immunoreactive HTLV-I/II ENV and POL peptides | |
| WO1993002102A1 (en) | Novel peptide antigens and immunoassays, test kits and vaccines using the same |